BTV News Alert Video: Algernon Pharmaceuticals Inc. - Trial Complete for COVID-19 Treatment

Vancouver, British Columbia--(Newsfile Corp. - February 11, 2021) - Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF) - The company has concluded a trial for Ifenprodil and is expecting to report on the data by the end of February. They are hopeful that Ifenprodil will be found to reduce the severity and the duration of a COVID-19 infection.

If you cannot view the video above, please visit:
https://b-tv.com/algernon-pharmaceuticals-trial-complete-for-covid-19-treatment-news-alert-30sec/

Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF)

Algernon Pharmaceuticals is being featured on BNN Bloomberg on Feb 15^th to 28^th, 2021, throughout the day and evenings.

algernonpharmaceuticals.com

About BTV:

BTV-Business Television is Canada's longest running business show. With Hosts Taylor Thoen and Jessica Katrichak, BTV features emerging companies across the country to bring viewers investment opportunities. BTV also produces News Alerts and branding/awareness spots for issuers broadcast on BNN Bloomberg, Fox Business News, Bloomberg TV US and Bloomberg Terminals. www.b-tv.com

BTV - Business Television/CEO Clips Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/74282